DOROTHY PERILLO: Open Payments
NPI 1447336599 · HAZLETON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,720 in 74 payments from 11 companies in 2025. Trend: 2023 $1,054 · 2024 $1,065 · 2025 $1,720
Food & beverage: $1,525Education: $195
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 24 | $419 |
| Alkermes, Inc. | 7 | $239 |
| Otsuka America Pharmaceutical, Inc. | 10 | $224 |
| E.R. Squibb & Sons, L.L.C. | 4 | $202 |
| Vanda Pharmaceuticals Inc. | 6 | $160 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $156 |
| Biogen, Inc. | 1 | $120 |
| Neurocrine BioSciences, Inc. | 3 | $58 |
| Axsome Therapeutics, Inc. | 2 | $57 |
| Janssen Pharmaceuticals, Inc | 2 | $45 |
Products named: COBENFY, UZEDY, CAPLYTA, ABILIFY MAINTENA, FANAPT, LYBALVI, ZURZUVAE, ARISTADA.
Industry payments across PA — which companies pay providers there.
